pamiparib,olaparib
merck,beigene,astrazeneca
['pamiparib']
(1/2) today dr. announced initial results from our phase 0 clinical trial evaluating pamiparib in patients with #glioblastoma (nct04614909) at . #esmo22 : 
Largest #Phase0 clinical trials program in the world providing personalized treatment options for patients with #glioblastoma & other aggressive brain tumors.